Zobrazeno 1 - 10
of 283
pro vyhledávání: '"M Osmak"'
Autor:
M. Osmak
Publikováno v:
Вісник Київського національного університету імені Тараса Шевченка. Серія Економіка, Vol 4, Iss 169, Pp 32-39 (2015)
The paper describes the characteristics of a modern model of fertility and family planning in Ukraine. The transformation of the age model of fertility and changes in the structure of fertility by birth order have been describes. Modern features of t
Externí odkaz:
https://doaj.org/article/eb8f731408b846438b835a3c77762515
Publikováno v:
International endodontic journal. 36(5)
To study in vitro the cytotoxic and mutagenic effects of AH26 and AH Plus.Cytotoxic effects on Chinese hamster V79 cells were determined by counting viable cells following incubation with eluations of AH26 and AH Plus. In one set of experiments, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cf426bd5bb13b2127dda395fce6532ba
https://pubmed.ncbi.nlm.nih.gov/12752646
https://pubmed.ncbi.nlm.nih.gov/12752646
Autor:
M, Sprem, D, Babić, M, Abramić, I, Vrhovec, J, Skrk, D, Milicić, A, Ambriović Ristov, D, Kalafatić, M, Osmak
Publikováno v:
Croatian medical journal. 42(6)
To determine the activity of glutathione (GSH) and concentrations of glutathione S-transferases (GST), urokinase type plasminogen activator (uPA), and plasminogen activator inhibitor type 1 (PAI-1), and to evaluate their diagnostic and prognostic val
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f486bb911268b503e9dc9659528a643a
https://pubmed.ncbi.nlm.nih.gov/11740844
https://pubmed.ncbi.nlm.nih.gov/11740844
Publikováno v:
Anticancer research. 21(1A)
In our previous work we showed that the drug-resistance of cervical carcinoma, laryngeal carcinoma and glioblastoma cells may be accompanied by increased levels of tumor markers for invasion and metastasis (i.e. urokinase-type plasminogen activator,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::82d52c856fcf20d138f313aeec3edf84
https://pubmed.ncbi.nlm.nih.gov/11299783
https://pubmed.ncbi.nlm.nih.gov/11299783
Autor:
L, Vuković, M, Osmak
Publikováno v:
Neoplasma. 46(6)
The effectiveness of carboplatin in the treatment of patients with tumors is limited by drug resistance. Because of that, there is a great interest to find a way to revert the resistance and improve the success of cancer treatment. The aim of the pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e627793f3af3003ea92628b427a6ea63
https://pubmed.ncbi.nlm.nih.gov/10732861
https://pubmed.ncbi.nlm.nih.gov/10732861
Publikováno v:
Anticancer research. 19(4B)
The association between drug-resistance and three markers for invasive capacity: cathepsin D (Cath D), urokinase type plasminogen activator (uPA) and inhibitor of plasminogen activator type 1 (PAI-1) was examined in nine cervical and laryngeal carcin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8264ea980b05aff6cb5b16915bf28613
https://pubmed.ncbi.nlm.nih.gov/10652611
https://pubmed.ncbi.nlm.nih.gov/10652611
Publikováno v:
European Journal of Cancer Supplements. 7:94-95
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::189f2de48c2fe5124b677e224f50d43d
https://doi.org/10.1016/s1359-6349(09)70319-2
https://doi.org/10.1016/s1359-6349(09)70319-2
Publikováno v:
Neoplasma. 46(4)
Most studies indicate that modulation of glutathione metabolism may be one of the most promising means of reversing clinical drug resistance. Five new diazene compounds have been synthesized: JK-279, JK-835, JK-913, JK-925 and LV-57 that should, acco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9a845cf1279d0d0040923a0c92103bda
https://pubmed.ncbi.nlm.nih.gov/10613598
https://pubmed.ncbi.nlm.nih.gov/10613598
Publikováno v:
Neoplasma. 45(4)
In our previous paper we have described the isolation and characterization of a doxorubicin (DOX) resistant subline of breast adenocarcinoma SC6 cells. These cells were obtained after the treatment with low, clinically relevant doses of doxorubicin.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::02b823ff69ee7852c252c62d3c494269
https://pubmed.ncbi.nlm.nih.gov/9890665
https://pubmed.ncbi.nlm.nih.gov/9890665
Publikováno v:
Neoplasma. 44(3)
Doxorubicin shows a wide spectrum of activities in solid tumors, especially against breast carcinoma. The aim of this study was to examine if doxorubicin, when given at lower concentrations than applied in clinic, may induce changes in treated cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::491d74afaaad6356df561473f31e2ed8
https://pubmed.ncbi.nlm.nih.gov/9372856
https://pubmed.ncbi.nlm.nih.gov/9372856